The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Moderna (MRNA) stock is reacting to reports of the US Department of Health and Human Services (HHS) reconsidering its bird flu vaccine deal with the drug maker. Yahoo Finance senior health reporter ...